Warchi /iStockphoto.com
19 December 2017Big Pharma
European Commission closes Roche investigation
The European Commission has closed an investigation into Roche which centred on the company’s pharmacovigilance duties.
Already registered?
Login to your account
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk
Big Pharma
5 July 2016 The European Medicines Agency announced yesterday that it has concluded its second inquiry in its case against pharmaceutical company Roche centring on the company’s pharmacovigilance duties.
Americas
27 July 2021 Roche has drawn criticism from an English High Court judge over its ‘disproportionate” demand for nearly $2.3m in costs, after it won a patent dispute with medical device company Insulet over a tubeless insulin pump.
Editor's picks
Editor's picks
Big Pharma
5 July 2016 The European Medicines Agency announced yesterday that it has concluded its second inquiry in its case against pharmaceutical company Roche centring on the company’s pharmacovigilance duties.
Americas
27 July 2021 Roche has drawn criticism from an English High Court judge over its ‘disproportionate” demand for nearly $2.3m in costs, after it won a patent dispute with medical device company Insulet over a tubeless insulin pump.
Big Pharma
5 July 2016 The European Medicines Agency announced yesterday that it has concluded its second inquiry in its case against pharmaceutical company Roche centring on the company’s pharmacovigilance duties.
Americas
27 July 2021 Roche has drawn criticism from an English High Court judge over its ‘disproportionate” demand for nearly $2.3m in costs, after it won a patent dispute with medical device company Insulet over a tubeless insulin pump.